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Introduction
The interactions between hormones,
epilepsy, and antiepileptic drugs (AEDs)
are complex. While there is ample evi-
dence that hormones inﬂuence epilepsy,
it is also apparent that epileptic activity
inﬂuences hormones in both women and
men. In addition, AEDs may disturb
endocrine function. The clinical impor-
tance of these interactions is primarily
related to the eﬀects on reproductive
hormones and is the focus of this article.
Reproductive endocrine dysfunction is
common among women and men with
epilepsy [1]. Menstrual disorders, poly-
cystic ovaries, and infertility have been
described among women with epilepsy
[1–3], while reduced potency and sperm
abnormalities have been found in men
[1, 4–5]. Sexual problems [6] and en-
docrine changes have been described
frequently in both sexes [1–3]. There are
also, however, interactions with other
hormones, especially thyroid hormones
(see [7]).
The close interplay between hor-
mones, epilepsy, AEDs, psychosocial
factors, comorbid conditions, and other
non-epilepsy medication means that
studying the eﬀects of each factor in
isolation can be problematic. However,
animal models and experimental models
using human tissue allow us to inves-




The impact of the epilepsy itself on en-
docrinefunctionhasbeenrecognisedand
discussed formanyyears. Clinical studies
have shown that epilepsy itself aﬀects the
secretion of pituitary hormones, thereby
aﬀecting the secretionpattern, rhythmic-
ity, and levels of the peripheral sex steroid
hormones [1, 8]. Even lateralityof epilep-
tic activitymay be important, as there are
some indications that left-sided temporal
foci increase the occurrence of polycys-
tic ovaries in women, while right-sided
foci increase the frequency of hypogo-
nadotropic hypogonadism [9].
Anatomical and neurophysiological
studies of tissue from animals and hu-
mans have shown that there is a close
connection between the temporolimbic
system and the hypothalamus, which
controls the neuroendocrine system.
The amygdala, in particular, has exten-
sive direct reciprocal connections with
regions of the hypothalamus that are
involved in the regulation, production,
and secretion of gonadotropin-releas-
ing hormones (GnRH). In line with
this, early studies demonstrated how
amygdala-kindling in male cats led to
hyposexuality [10], and limbic seizures
elicited in female rats resulted in inter-
ruption of the estrous cycle and altered
mating behavior [11]. Stimulation of
the corticomedial amygdala can induce
ovulation and uterine contractions in
several species [12–13]. Bilateral amyg-
dalectomy in adult male rats and cats
has been found to cause marked degen-
eration of the testes [14], and bilateral
ablations of the amygdala in adult female
deer mice can induce anovulatory cycles
and polycystic ovaries [15]. In addi-
tion, bilateral amygdalectomy in female
monkeys induces amenorrhea and hy-
pogonadal vaginal changes [16]. These
studies demonstrate the close interac-
tions between neuronal hyperactivity
or hypoactivity in the temporolimbic
brain areas and reproductive endocrine
function.
A series of experiments conducted by
Edwardsandco-workers [17–18] showed
the eﬀects of seizures on reproductive
functions in both female and male rats.
In females, amygdala-kindled seizures
halted ovarian cyclicity and also caused
high serum estradiol concentrations, in-
creased pituitary weight, theca cell hy-
perplasia, and polyfollicular ovaries con-
sisting of many cystic follicles, as well as
follicles in various stages of growth and
atresia. Progesterone treatment, which is
used to restore cyclicity, was eﬀective in
only 5 of the 28 animals that had stopped
cycling, while all sham-kindled controls
that had stopped cycling regained cyclic-
ity. For intact male animals, amygdala-
kindled seizures resulted in an increase
in serum testosterone, estradiol, and pro-
lactin, which was accompanied by a sig-
niﬁcant increase in testis, epididymis,
and pituitary weight, as well as a signif-
icant decrease in prostate weight. Maxi-
mal electroshock seizures (MES) caused
a short-term reduction in serum testos-
terone concentrations and in testis, epi-
didymis, andprostateweight. Theseﬁnd-
ings demonstrate that both focal limbic
(amygdaloid) seizures and generalized
(MES) seizures disturb the normal repro-
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Fig. 18 Photomicrographs of hypothalamic nuclei from a right-amyg-
dala-stimulated rat.a, c Similar numbers of Fos-ir neurons on the left and
right-hand sides of themedial preoptic area (MPA) andparaventricular
hypothalamic nucleus (PVH), areas not involved in reproductive endocrine
function. b, d, e Laterally asymmetric, ipsilaterally predominating numbers
of Fos-ir neurons in themedial preoptic nucleus (MPO), ventrolateral part
of the ventromedial hypothalamic nucleus (VMH), and in the ventral pre-
mamillary nucleus (PMV), areas that are involved in reproductive function
and reproductive endocrine secretion. (Copyright JohnWiley & Sons Inc.
[19])
ductive physiology in rats, independently
of AEDs or other confounding factors.
The demonstration that diﬀerent
endocrine responses depend on the lat-
erality of the epileptic activity provides a
ﬁrm indication of the direct inﬂuence of
epilepsy on endocrine function. Silveira
and co-workers [19] reported asymmet-
ric activation of hypothalamic regions
after unilateral amygdala-stimulated
seizures. By studying Fos-immunore-
activity in diﬀerent hypothalamic areas,
they identiﬁed three areas that are promi-
nently involved in reproductive function,
including the medial preoptic nucleus
(MPO), the ventrolateral part of the
ventromedial hypothalamus (VMHVL),
and the ventral premammillary nucleus
(PMV).These areas showed signiﬁcantly
greater and more asymmetric, ipsilater-
ally predominating induction of Fos fol-
lowing unilateral amygdala-stimulated
seizures than other regions investigated,
which are not involved in reproductive
endocrine function (. Fig. 1). Asym-
metric activation of the hypothalamus
could be the basis for the occurrence
of such reproductive endocrine disor-
ders in patients with left-sided or right-
sided temporal lobe epilepsy, since there
is a clear asymmetry in the reproductive
functions of the hypothalamus, includ-
ing asymmetric content of GnRH [20].
These animal studies provide a deﬁni-
tive demonstration of a direct eﬀect of
epilepsy and epileptic discharges on re-
productive endocrine function.
Eﬀects of hormones on epilepsy
Both female and male sex steroid
hormones inﬂuence brain excitability.
Among the female sex steroid hor-
mones, progesterone and its metabolites
are anticonvulsant, while estrogens are
mainly proconvulsant. Androgens are
also mainly anticonvulsant, but their
eﬀects are more varied, probably due to
the metabolism of androgens to, among
others, estradiol.
Estrogens
Application of estrogen directly to the
cortex has potent epileptogenic eﬀects
[21], while topical application of es-
trogen has even been used as a model
of focal epilepsy (see [22]). Estradiol
also reduces the electroshock threshold,
increases paroxysmal spiking in epilepto-
genic foci in cats and rabbits, facilitates
kindling, and potentiates seizures in-
duced by diﬀerent chemoconvulsants
(see [23]).
Of considerable importance for the
generally excitatory eﬀect of estrogens
is their ability to enable the rapid in-
crease in responses of neurons to the
excitatory eﬀect of glutamate [24–26].
This potentiating eﬀect is thought to pri-
marily inﬂuence NMDA, but also non-
NMDA types of glutamate receptors (see
[26]). The excitatory responses to glu-
tamate are increased by estradiol in a
dose-dependent manner [24–25]. Typi-
cally, enhancement of glutamate excita-
tion occurs within seconds after onset
of local steroid application, indicative of
an eﬀect onmembrane-bound glutamate
receptors.
GABA-ergicmechanismsdonot seem
to be aﬀected as an acute response [24,
27], but estrogens do aﬀect the GABA-
ergic system over time. Prolonged ex-
posure (more than 24 hours) to estra-
diol suppresses GABA-ergic inhibition
of hippocampal neurons that may be re-
lated to decreased GABA release at in-
hibitory synapses (see i.e. [28]). Also, it is
assumed that estradiol decreases GABA




Estradiol has also been found to al-
ter brain morphology by increasing den-
dritic spine density via an NMDA re-
ceptor-dependent mechanism and alter-
ing the pattern of hippocampal synap-
tic connectivity [26, 33–35]. Estradiol
selectively increased neuronal sensitiv-
ity to synaptic input mediated by the
NMDA type of glutamate receptor, while
responses mediated by the AMPA recep-
tor were not aﬀected. These continuous,
plastic changes in morphology that are
related tospinedensityandneuronal sen-
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sitivity toglutamate areprobablyofmajor
importance with respect to the eﬀect of
estrogens on brain excitability.
Estrogens may be anticonvulsant in
particular circumstances. As with other
peripheral sex steroid hormones, estro-
gens also exert their eﬀect at intracellu-
lar receptors, the estrogen receptors, ERα
and ERβ. Of these, the eﬀect of ERβ is
the most important for the non-repro-
ductive eﬀects of the hormone, and some
experiments have found that lowdoses of
estrogen may actually reduce seizures by
acting at ERβ (see [36]), while long-term
estrogen exposure may decrease the sus-
ceptibility to kainate-induced seizures in
some cases (see [28]).
Progesterone and its metabolites
Progesterone and its metabolites have
been shown to increase the electroshock
threshold [37, 81], protect against au-
diogenic and pentylenetetrazol (PTZ)-
induced seizures, inhibit kindling, and
also to protect against electroshock-in-
duced seizures (see i. e. [23]).
The main mechanisms by which pro-
gesterone and its metabolites exert their
eﬀect on brain excitability are non-
classical, being related to membrane
receptors. Progesterone receptors are
widely distributed in the brain (see [38])
andprogesterone circulating in the blood
gains rapid, and relatively unrestricted,
access to all parts of the nervous system
[39–40]. Neural tissue is able to convert
progesterone to more potent antiepilep-
togenic progesterone metabolites within
the brain (see [41]).
The main eﬀects of progesterone
and its metabolites are considered to
be related to an enhanced postsynaptic
GABA-ergic eﬀect, as evidenced by sev-
eral lines of investigation. Progesterone
and its metabolites increase the inward
chloride current induced by GABA [37,
42], increase the binding of muscimol
[37, 43], stimulate the binding of ﬂu-
nitrazepam [44], and displace TBPS
binding to the GABA receptor complex
[44–45]. The eﬀects on GABA-ergic in-
hibition of 3α-5α-THP, the most potent
antiepileptogenic metabolite of proges-
terone, were investigated by Majewska
et al [42], and dose-dependent increases
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Abstract
Reproductive endocrine dysfunction is
common among both women and men
with epilepsy. The reasons for this are
multifactorial and bidirectional; epilepsy can
aﬀect hormones, and hormones can aﬀect
seizures. Furthermore, several antiepileptic
drugs (AEDs) can have endocrine side-eﬀects,
while psychosocial factors and co-morbidity
add further complexity. Animal models and
experimental models using human tissue
or cell lines provide new approaches to
investigating the independent eﬀects of
the epilepsy itself, hormonal eﬀects, and
the eﬀects of AEDs, in isolation and without
confounding factors. This paper reviews
the literature regarding animal studies and
selected experiments using human cell
lines related to reproductive endocrine
function in epilepsy. By comparing results
from clinical and experimental studies and
by developing appropriate animal models,
several mechanistic questions regarding
the complex interplay between epilepsy,
hormones, and AEDs can be explored. Animal
experiments should be an integral tool in the
study of reproductive endocrine disorders in
epilepsy.
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Experimentelle Modelle zum Studiumhormoneller
Veränderungen bei Epilepsie
Zusammenfassung
Reproduktive endokrine Dysfunktion ist
sowohl bei Männern als auch bei Frauen
mit Epilepsie verbreitet. Die Gründe dafür
sind vielschichtig und wechselseitig:
Epilepsie kann Hormone beeinﬂussen,
Hormone können epileptische Anfälle
begünstigen. Darüber hinaus können etliche
antiepileptische Medikamente (AEDs)
endokrine Nebenwirkungen haben, und
psychosoziale Faktoren sowie Komorbidität
steigern noch die Komplexität des Problems.
Tiermodelle oder experimentelle Modelle
mit menschlichemGewebe oder Zelllinien
ermöglichen neue Ansätze zur Erforschung
der unabhängigen Auswirkungen der
Epilepsie selbst, der Hormone sowie der
AEDs, jeweils eigenständig und ohne
Störfaktoren. Dieser Beitrag gibt einen
Überblick über die Literatur zu Tiermodellen
und ausgewählten Experimenten mit
menschlichen Zelllinien in Verbindung mit
reproduktiver endokriner Dysfunktion bei
Epilepsie. Im Vergleich der Ergebnisse von
klinischen und experimentellen Studien
sowie durch die Entwicklung entsprechender
Tiermodelle können etliche mechanistische
Fragestellungen zu dem komplexen Zusam-
menspiel zwischen Epilepsie, Hormonen und
AEDs sondiert werden. Tierstudien sollten ein
wesentliches Hilfsmittel für die Erforschung
von reproduktiven endokrinen Dysfunktionen
bei Epilepsie sein.
Schlüsselwörter
Epilepsie · Antiepileptika · Hormone ·
Tiermodelle · Geschlechterfragen
in both peak amplitude and duration of
the inward chloride current induced by
GABA were demonstrated. In line with
this, the eﬀects of both progesterone and
3α-5α-THPonrecurrentGABA-ergic in-
hibition have also been observed in hip-
pocampal slices from rats [82].
The mechanisms by which the eﬀect
on GABA-ergic induced chloride inﬂux
is exerted and exactly where the steroid
binds to the GABA-A receptor complex
have been discussed. In the mid-1980 s
the eﬀect on chloride inﬂux was shown
to be largely related to an increase in
the eﬀective open time of the chloride
channels [46]. However, although this
may be the most important mechanism,
later studies indicated that an increase in
opening frequency may also be involved
[47]. The binding site for progesterone
and its metabolites within the GABA-
A receptor complex is unique and dif-
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Fig. 28 Theeﬀectof levetiracetam(LEV)andvalproate (VPA)on(a)basaland(b)LH-stimulatedtestos-
terone secretion. Signiﬁcantdiﬀerences comparedwith control. *p<0.05; **p<0.01. (Copyright John
Wiley & Sons Inc. [67])
fers from that of both barbiturates and
benzodiazepines (BZ).
Progesterone and its metabolites may
also aﬀect excitatory mechanisms. A se-
ries of studies on Purkinje cells from
a rat cerebellum [48–50], demonstrated
that both progesterone itself and several
of its metabolites, including 3α-5α-THP,
decreased glutamate responsiveness after
either systemic or topical application.
Seizure susceptibility may also be al-
tered by changes in the subunit com-
position of the GABA-A receptor. The
most striking ﬁnding following proges-
terone withdrawal, a model for catame-
nial epilepsy, is themarkedup-regulation
of the α-4 subunit of the GABA recep-
tor [23, 51–54], which is insensitive to
BZ. The increase in α-4 expression also
leads to a decrease in inhibition gated
by the GABA-A receptor (see [26]). Dy-
namicchangesintheGABAreceptorsub-
unit composition in situations with pro-
gesterone withdrawal, which occurs pre-
menstrually, also alter the seizure thresh-
old and sensitivity to AED treatment on
a cyclic basis. In this context, it is of rel-
evance that some neurosteroids may be
able to modulate all isoforms of GABA-
A receptors, including those containing
the α-4 subunit. This provides possi-
bilities for speciﬁc treatment of women
with catamenial epilepsywithnewdrugs,
suchasGanaxalone– inessenceaneuros-
teroid, which also acts at the α-4 subunit.
Although the eﬀects on non-clas-
sical mechanisms are by far the most
important for the role of progesterone
and its metabolites as anticonvulsants,
a possible eﬀect on intracellular, clas-
sical progesterone receptors cannot be
completely ruled out. A series of experi-
ments, mainly on PTZ-induced seizures
in ovariectomized rats, suggested a
possible role for classical progesterone
receptors as being relevant for the anti-
convulsant eﬀect [36].
Androgens
Although a general anti-seizure eﬀect
is most commonly observed, androgens
have more varied eﬀects [55]. Adminis-
tration of androgens directly to the hip-
pocampus of castrated rats reduces PTZ-
induced seizures, while testosterone in-
creases the electroconvulsive threshold
in males at low dose, but in both sexes
at higher doses (see [56]). The vari-
able actions of testosteronemay partly be
due to its metabolism to 17β-estradiol,
which is generally excitatory, but also to
androstanediol and dihydrotestosterone,
which exert potent antiepileptic eﬀects
(see [55]).
Regarding their role in epilepsy, an-
drogens act primarily at non-classical,
membrane receptors [57–58], as pow-
erful and positive modulators of the
GABA-A receptor. For instance, Reddy
and Jian [58] showedhowandrostanediol
produced a concentration-dependent
enhancement of GABA-activated cur-
rents. Systemic doses of androstanediol
(5–100 mg/kg) resulted in a dose-depen-
dent suppression of seizures in a mouse
hippocampal kindling model, which is
a model of temporal lobe epilepsy, with
high doses providing complete seizure
protection.
Androgens also have eﬀects on neu-
ronal structure, increasing the number of
spine synapses in the stratum radiatum
of area CA1 in the rat hippocampus [59].
Androgens may also aﬀect spine synapse
density in thehippocampus in female rats
and contribute to plastic changes over the
course of the menstrual cycle [60].
Similar to the other sex steroids, an-
drogens also act at classical, intracellular
receptors, as demonstrated by the pro-
convulsant eﬀect of ﬂutamide, an antag-
onist of the intracellular androgen recep-
tor. Further, it has been shown that tes-
ticular feminized mice, which are totally
insensitive toandrogensdue tomutations
in the intracellular androgen receptor, do
not exhibit the anti-seizure eﬀects from
exposure to androgens that are observed
in wildtype animals with intact intracel-
lular androgen receptors (see [55]).
Endocrine eﬀects of AEDs on sex
steroid hormones
Several AEDs exert a direct eﬀect on the
production of sex steroid hormones. The
ﬁrst study to address this question in
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Fig. 38 Theeﬀectof levetiracetam(LEV)andvalproate(VPA)on(a)basaland(b)FSH-stimulatedestra-
diol secretion. Signiﬁcant diﬀerences comparedwith control. *p < 0.05; **p < 0.01. (Copyright John
Wiley & Sons Inc. [67])
animals was published in 1990 and in-
vestigated the eﬀects of valproate (VPA),
carbamazepine (CBZ), and phenytoin on
diﬀerent steps of testosterone biosynthe-
sis in isolated rat Leydig cells [61]. Us-
ing submaximally stimulatingconcentra-
tions of human chorionic gonadotropin
(hCG), leading to physiological testos-
teronesecretionrates, half-maximal inhi-
bitionof testosterone formationoccurred
in the presence of 15 μM CBZ, 180 μM
phenytoin, or 900 μMVPA.Only the val-
ues for CBZ were in the clinically ther-
apeutic range.
Some, but not all, BZ may alter an-
drogen production, perhaps due to the
selective eﬀects of diﬀerent BZonvarious
types of BZ receptors. Peripheral-type
BZ receptors have been characterized in
various tissues like the ovary and testis.
Clonazepam, which acts only on the cen-
tral-type BZ receptors, did not aﬀect an-
drogen production, whereas diazepam,
which binds to both central and periph-
eral BZ receptors, induced a signiﬁcant
increment of basal and hCG stimulated
testosterone production [62]. However,
other studies found that chronic treat-
ment of male rats with diazepam is asso-
ciated with lowered serum testosterone
levels [63]. As there was no diﬀerence in
serum the luteinizing hormone (LH) and
the follicle-stimulating hormone (FSH),
nor in the hypothalamic luteinizing hor-
mone-releasing hormone (LHRH) con-
tent, itwassuggested thatdiazepamcould
act directly on the testicular interstitial
cells to reduce testosterone production
[63]. This is supported bydata that shows
that the peripheral-type BZ receptor ag-
onist Ro 5-4864 aﬀects androgen pro-
duction from suspensions of isolated rat
interstitial cells, suggesting that BZ act-
ing on peripheral BZ receptors have a
direct eﬀect on Leydig cells [62].
Long-term AED treatment may have
profound eﬀects on reproductive en-
docrine function. Due to the heated
debate on the possible eﬀects of VPA,
the majority of studies focused on this
drug. However, it should be borne in
mind that the lack of reported eﬀects on
reproductive endocrine function from
other drugs does not imply that they
have been proven to be without such
eﬀects.
Long-term VPA treatment in female,
non-epileptic rats has been shown to re-
sult in a marked increase in the testos-
terone/estrogen ratio, mainly by decreas-
ing estrogen levels [64]. Regarding the
gonadotropins, there was no increase in
LH after VPA treatment; indeed, a trend
towards reduced LH levels at high VPA
doses was observed. No change was seen
in FSH levels. Lamotrigine, on the other
hand, did not aﬀect any of the hormones
studied. Taken together, the eﬀects of
long-term VPA treatment, with a pro-
nounced reduction in estrogen concen-
trations, a notable increase in the testos-
terone/estrogen ratio, and minor eﬀects,
if any, on gonadotropins, suggest that
VPA has a direct eﬀect on the produc-
tion of peripheral sex steroid hormones
in the ovary.
In order to investigate the possibil-
ity of a direct eﬀect of VPA on follic-
ular steroidogenesis in more detail, the
secretion of testosterone and estradiol
from isolated porcine ovarian follicles
has been studied [65]. In this study,
co-cultures of theca and granulosa cells
were used. Such co-cultures are thought
to provide a better reﬂection of the in
vivo situation than models using isolated
cell cultures, as theca cells and granu-
losa cells work closely together in vivo as
a functional unit. Using concentrations
from 600 to 1500 μmol/l VPA, which in-
cludes clinically relevant concentrations,
it was shown that VPA increased the se-
cretion of testosterone, decreased estra-
diol secretion, and reduced the conver-
sion of testosterone to estradiol. Two
subsequent studies conﬁrmed and ex-
tended these ﬁndings [66–67]. VPA was
demonstrated to cause a signiﬁcant in-
crease in LH-stimulated testosterone se-
cretion and a decrease in FSH-stimu-
lated estradiol secretion (Fig. 2 and 3).
VPA also decreased conversion of testos-
terone to estradiol in both basal and FSH
stimulated cultures. This is of possible
clinical importance as gonadotropins are
always present in fertile women. These
ﬁndings have been conﬁrmed in stud-
ies using human ovarian follicular cells,
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which showed that VPA caused a sig-
niﬁcant and dose-dependent decrease in
basalandFSH-stimulatedestradiol secre-
tion. Further, VPA reduced CYP19 aro-
matase activity in FSH-stimulated cells
at higher concentrations [66].
VPA may also alter enzyme activities
and gene expression. In long-term cul-
tures of human theca cells treated for
72 hwith sodiumVPA (30–3000 μmol/l),
Nelson-deGrave and co-workers [68]
observed an increase in basal and
forskolin-stimulated dehydroepiandros-
terone (DHEA), androstenedione, and
17alpha-hydroxyprogesterone produc-
tion. Themost pronounced eﬀect ofVPA
onandrogenbiosynthesis occurred in the
dose range of 300–3000 μmol/l, which
includes therapeutic levels for the treat-
ment of epilepsy and bipolar disorder.
The study also showed that VPA can in-
crease dehydroepiandrosterone (DHEA)
and androstenedione and increase the
expression ofCYP17 andCYP11A genes,
as seen in polycystic ovary syndrome.
Thus, VPA may have a direct eﬀect on
steroidogenesis by aﬀecting gene expres-
sion, converting normal theca cells to
a polycystic ovary phenotype. In line
with this, Gustavsen et al [69] used a
model of human adrenal carcinoma cells
that are capable of full steroidogenesis to
show that VPA reduced estradiol levels
and caused a general down-regulation
of expression of genes encoding for en-
zymes early in steroidogenesis. Using
the same cell line, gene analyses sug-
gested thatVPAaﬀectsNR0BIexpression
[70]. NR0BI inhibits promoters of other
genes involved in steroidogenesis, and
the altered expression of NR0BI might
explain the observed down-regulation
in hormone production. In the same
study, expression of CYP19 was reduced
following exposure to 900 μmol/l of
VPA, which is a clinically relevant con-
centration. The CYP19 gene codes for
aromatase catalyse androgens to estro-
gens, which is in line with the reduced
conversion of testosterone to estradiol
[67].
A direct eﬀect of VPA is further sup-
ported by the ﬁndings of Hattori et al.
[71], who demonstrated the presence of
the enzyme microsomal epoxide hydro-
lase (mEH) in human ovaries. mEH
is important in detoxiﬁcation of vari-
ous substances, and several studies have
shown that VPA inhibits mEH activity
[72]. Hattori et al. [71] showed that hu-
man granulosa cells expressedmEH, and
that inhibition of mEH suppressed con-
version of testosterone to estradiol. The
action of VPA as an inhibitor of mEH
may represent a route by which VPA re-
duces estrogen levels, thereby increas-
ing the testosterone/estrogen ratio. This
will lead to an androgen-dominant mi-
croenvironment in theovary, and thereby
possibly to polycystic changes, without
an increase in LH levels [71].
However, a study in Rhesus monkeys
[73] indicates a lack of endocrine ef-
fects after long-termtreatmentwithVPA.
Only 7 animals were studied, and this
study also demonstrated a trend towards
an increase in testosterone/estrogen ra-
tio, lower estrogen levels, and an elevated
LH: FSH ratio. In addition, body weight
was signiﬁcantly increased.
It is important that the potential direct
eﬀects of drugs other than VPA should
also be investigated in more detail, es-
pecially “newer” AEDs. Levetiracetam
(LEV) is of particular interest as it binds
tothesynapticvesicleprotein, SV2A[74].
SV2A iswidelydistributed in thenervous
systemand also in endocrine tissue. LEV
may exert its eﬀect both at the central and
peripheral level as SV2A is expressed in
the pituitary gland and the hypothala-
mus, but also in the ovary. In a primary
investigation on the possible endocrine
eﬀect, we showed that LEV aﬀected only
basal, but not gonadotropin-stimulated,
testosterone and estrogen secretion from
porcine ovarian follicular cells [67]. This
suggests that LEV could be an alternative
drug for women of fertile age, as their
gonadotropin status resembles the situa-
tion of gonadotropin stimulation. How-
ever, shortly after this ﬁrst report was
published, Svalheim et al [75] showed
that long-term treatment of healthy fe-
male rats with LEV resulted in endocrine
changes, with increased testosterone and
reduced estradiol levels. In addition,
there was a dose-dependent increase in
ovaryweight and an increase in the num-
ber of corpora lutea and secondary folli-
cles, but no eﬀect on number and dimen-
sion of ovarian cysts. These changeswere
observed at therapeutically relevant drug
concentrations. It is also important to
note that the changes diﬀered from those
associated with exposure to VPA, and
thus represent a drug-speciﬁc pattern.
Nevertheless, three more recent studies
did not conﬁrm any eﬀect of LEV onhor-
moneproductionandexpressionofgenes
related to steroidogenesis in both human
adrenal cells (H295R cells) [69–70] and
in human ovarian follicular cells [66]. In
sum, at present LEV may be considered
to have minor, if any, endocrine eﬀects.
Topiramate is another drug that has
been studied brieﬂy with regard to en-
docrine eﬀects, and was found to reduce
fertility and ovarian weight in female
rats that were exposed (100 mg/kg) for
12weeks [76]. Inmale rats given the same
dose for 8 weeks led to decreased sper-
matogenesis, sperm motility, and weight
of reproductive organs [77]. However,
although the serum concentrations were
not measured and the clinical relevance
of the observations is uncertain, these re-
sults underline the importance of study-
ing all AEDs more closely with regard to
possible endocrine eﬀects.
Sex steroid hormones may also be in-
ﬂuenced by AEDs via a centrally medi-
ated eﬀect by altering gonadotropin se-
cretion. A study inmale rats [64]demon-
strated a dose-dependent increase in LH
after long-term VPA treatment and also
an increase in FSH at the highest dose.
While this ﬁnding considered in isolation
might imply a direct eﬀect of the drug on
the central nervous system, the increased
gonadotropin levels may also be consid-
ered as compensatory mechanisms that
are related to the marked peripherally
induced eﬀects observed in the animals.
The lack of a centrally mediated eﬀect is
supported by the ﬁnding of unchanged
FSH and prolactin levels in mice after
8 weeks of VPA treatment at doses that
led to a reduction in pubertal maturation
and alterations in ovarian and testicu-
lar function [78]. However, long-term
VPA treatment has been shown to de-
layGnRHcellmorphologicalmaturation
within the hypothalamus in young mice,
although not in adults [79]. Long-term,
low-dose, VPA or CBZ treatment in rats
has also been shown to increase prolactin
concentrations and reduce FSH and LH
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levels in male rats [80]. Furthermore, it
should be remembered that GABA-ergic
mechanisms are involved in the secre-
tion of GnRH at the hypothalamic level,
and several of our most commonly used
AEDs exert their eﬀects through actions
on the GABA receptor. Thus, a centrally
mediated eﬀect of AEDs on sex hormone
regulationcannotberuledoutandshould
be explored in further studies.
In conclusion, there is an intri-
cate multidirectional interplay between
epilepsy, sex steroid hormones, and
AEDs. The complexity of interactions
precludes investigation of the impact of
each individual factor in clinical studies.
Psychosocial aspects, comorbidity and
use of drugs for other indications than
epilepsy are further confounding fac-
tors. Animal models and experimental
models using human tissue allow us
to investigate the independent eﬀects
of the various factors. By comparing
results from clinical and experimental
studies several mechanistic questions re-
garding the complex interplay between
epilepsy, hormones, and AEDs can be
explored. Animal experiments should,
therefore, be an integral tool in the study
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